Drug recall
Apheresis Red Blood Cells, Leukocytes Reduced
FDA recall event 93435 · Class II · American National Red Cross (The)
Key facts
| Event ID | 93435 |
|---|---|
| Recall numbers | B-0053-2024 |
| Recalling firm | American National Red Cross (The) |
| Product type | Biologics |
| Products | Apheresis Red Blood Cells, Leukocytes Reduced |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Apheresis Red Blood Cell product, associated with invalid testing results, was distributed. |
| Initiation date | Sep 6, 2023 |
| Report date | Nov 29, 2023 |
| Termination date | Nov 21, 2023 |
| City | Johnstown |
| State | PA |
| Country | United States |
| FEI number | 2573016 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: